Overview
Background
I am an Organic Chemist and research the design and preparation of new medicines for diseases including arthritis and cancer
Dr. Robert C. Reid was awarded B.Sc. Hons 1 (1986) and Ph.D. (1990) degrees from the University of Sydney, Department of Organic Chemistry. He studied the stereospecific total synthesis of complex natural products with Professor Max J. Crossley and then undertook postdoctoral studies with Professor Sir Jack E. Baldwin FRS at the Dyson Perrins Laboratory, Oxford University UK (1990-93) studying the biosynthesis of penicillins. He is a Senior Research Fellow at the Institute for Molecular Bioscience (formerly known as the Centre for Drug Design and Development) at the University of Queensland with Professor David Fairlie. Research interests include Organic Synthesis, medicinal chemistry, drug design and development, nonpeptidic GPCR antagonists, natural products, protease inhibitors, other enzyme inhibitors, and peptidomimetics.
Availability
- Dr Robert Reid is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Bachelor (Honours) of Science (Advanced), University of Sydney
- Doctor of Philosophy of Organic Chemistry, University of Sydney
Works
Search Professor Robert Reid’s works on UQ eSpace
2009
Journal Article
The use of live-animal micro-computed tomography to determine the effect of a novel phospholipase A(2) inhibitor on alveolar bone loss in an in vivo mouse model of periodontitis
Cantley, M. D., Bartold, P. M., Marino, V, Reid, R. C., Fairlie, D. P., Wyszynski, R. N., Zilm, P. S. and Haynes, D. R. (2009). The use of live-animal micro-computed tomography to determine the effect of a novel phospholipase A(2) inhibitor on alveolar bone loss in an in vivo mouse model of periodontitis. Journal of Periodontal Research, 44 (3), 317-322. doi: 10.1111/j.1600-0765.2008.01132.x
2008
Journal Article
Crystal structures of highly constrained Substrate and Hydrolysis products bound to HIV-1 Protease. Implications for the Catalytic Mechanism
Tyndall, Joel D. A., Pattenden, Leonard K., Reid, Robert C., Hu, Shu-Hong, Alewood, Dianne, Alewood, Paul F., Walsh, Terry, Fairlie, David P. and Martin, Jennifer L. (2008). Crystal structures of highly constrained Substrate and Hydrolysis products bound to HIV-1 Protease. Implications for the Catalytic Mechanism. Biochemistry, 47 (12), 3736-3744. doi: 10.1021/bi7023157
2008
Journal Article
Clean Or dirty - Just how selective do drugs need to be?
Abbenante, Giovanni, Reid, Robert C. and Fairlie, David P. (2008). Clean Or dirty - Just how selective do drugs need to be?. Australian Journal of Chemistry, 61 (9), 654-660. doi: 10.1071/CH08186
2008
Book Chapter
Parallel synthesis af anticancer, antiinflammatory and antiviral agents derived from L- and D- amino acids
Reid, Robert, C. and Fairlie, David P. (2008). Parallel synthesis af anticancer, antiinflammatory and antiviral agents derived from L- and D- amino acids. High-throughput lead optimisation in drug discovery. (pp. 177-194) edited by Tushar Kshirsagar. Boca Raton, USA: CRC Press. doi: 10.1201/9781420006964.ch7
2007
Other Outputs
New amino acid derivatives useful for the treatment of inflammatory disease or condition e.g. rheumatic arthritis
Clark, C. I., Fairlie, D. P., Hansford, K., McGeary, R. P., Reid, R. C. and Stoermer, M. J. (2007). New amino acid derivatives useful for the treatment of inflammatory disease or condition e.g. rheumatic arthritis.
2007
Other Outputs
Compounds and inhibitors of phospholipases
Reid, Robert C., Clark, Christopher I., Hansford, Karl, Stoermer, Martin J., McGeary, Ross P., Fairlie, David P. and Schafer, Karl (2007). Compounds and inhibitors of phospholipases. US7253194.
2007
Journal Article
The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding
Scola, A. M., Higginbottom, A., Partridge, L, J., Reid, R. C., Woodruff, T., Taylor, S. M., Fairlie, D. P. and Monk, P. N. (2007). The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding. Journal of Biological Chemistry, 282 (6), 3664-3671. doi: 10.1074/jbc.M609178200
2007
Journal Article
Nonpeptidic ligands for peptide-activated G protein-coupled receptors
Blakeney, J. S, Reid, R. C, Le, G. T and Fairlie, D. P (2007). Nonpeptidic ligands for peptide-activated G protein-coupled receptors. Chemical Reviews, 107 (7), 2960-3041. doi: 10.1021/cr050984g
2006
Conference Publication
MEDI 181-Alpha helix induction in HIV REV34-50 by N-terminal nucleators
Beyer, Renee L., Kelso, Michael J., Reid, Robert C., Le, Giang T. and Fairlie, David P. (2006). MEDI 181-Alpha helix induction in HIV REV34-50 by N-terminal nucleators. WASHINGTON: AMER CHEMICAL SOC.
2006
Journal Article
Inhibitors of cyclo-oxygenase-2 and secretory phospholipase A2 preserve bone architecture following ovariectomy in adult rats
Gregory, Laura S., Kelly, Wendy L., Reid, Robert C., Fairlie, David P. and Forwood, Mark R. (2006). Inhibitors of cyclo-oxygenase-2 and secretory phospholipase A2 preserve bone architecture following ovariectomy in adult rats. Bone, 39 (1), 134-142. doi: 10.1016/j.bone.2005.12.017
2006
Journal Article
Antifibrotic activity of an inhibitor of group IIA secretory phospholipase A(2) in young spontaneously hypertensive rats
Levick, Scott, Loch, David, Rolfe, Barbara, Reid, Robert C., Fairlie, David P., Taylor, Stephan M. and Brown, Lindsay (2006). Antifibrotic activity of an inhibitor of group IIA secretory phospholipase A(2) in young spontaneously hypertensive rats. Journal of Immunology, 176 (11), 7000-7007. doi: 10.4049/jimmunol.176.11.7000
2006
Journal Article
Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria
Andrews, Katherine T., Fairlie, David P., Madala, Praveen K., Ray, John, Wyatt, David M., Hilton, Petrina M., Melville, Lewis A., Beattie, Lynette, Gardiner, Donald L., Reid, Robert C., Stoermer, Martin J., Skinner-Adams, Tina, Berry, Colin and McCarthy, James S. (2006). Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria. Antimicrobial Agents And Chemotherapy, 50 (2), 639-648. doi: 10.1128/AAC.50.2.639-648.2006
2006
Conference Publication
Alpha helix induction in HIV REV34-50 by N-terminal nucleators
Beyer, Renee L., Kelso, Michael J., Reid, Robert C., Le, Giang T. and Fairlie, David P. (2006). Alpha helix induction in HIV REV34-50 by N-terminal nucleators. 232nd ACS National Meeting, San Francisco, CA, U.S.A., 10-14 September, 2006. American Chemical Society. doi: 10.1021/cen-v084n034.p055
2005
Journal Article
Inhibitors of Secretory Phospholipase A2 Group IIA
Reid, Robert C. (2005). Inhibitors of Secretory Phospholipase A2 Group IIA. Current medicinal chemistry, 12 (25), 3011-3026. doi: 10.2174/092986705774462860
2005
Journal Article
A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induced colitis
Woodruff, Trent M., Arumugam, Thiruma V., Shiels, Ian A., Newman, Michelle L., Ross, Paul A., Reid, Robert C., Fairlie, David P. and Taylor, Stephen M. (2005). A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induced colitis. International Immunopharmacology, 5 (5), 883-892. doi: 10.1016/j.intimp.2005.01.003
2004
Journal Article
Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats
Arumugam, Thiruma V., Woodruff, Trent M., Stocks, Shelli Z., Proctor, Lavinia M., Pollitt, Sandra, Shiels, Ian A., Reid, Robert C., Fairlie, David P. and Taylor, Stephen M. (2004). Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats. Journal of Hepatology, 40 (6), 934-941. doi: 10.1016/S0168-8278(04)00066-2
2004
Journal Article
Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats
Arumugam, Thiruma V., Woodruff, Trent M., Stocks, Shelli Z., Proctor, Lavinia M., Pollitt, Sandra, Shiels, Ian A., Reid, Robert C., Fairlie, David P., Taylor, Stephen M. and M. Colombo (2004). Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats. Journal of Hepatology, 40 (6), 934-941. doi: 10.1016/j.jhep.2004.02.017
2004
Other Outputs
Compounds and inhibitors of phospholipases
Reid, Robert C., Clark, Christopher I., Hansford, Karl, Stoermer, Martin J., McGeary, Ross P., Fairlie, David P. and Schafer, Karl (2004). Compounds and inhibitors of phospholipases. US2004033995.
2004
Journal Article
Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury
Proctor, Lavinia M., Arumugam, Thiruma V., Shiels, Ian, Reid, Robert C., Fairlie, David P. and Taylor, Stephen M . (2004). Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury. British Journal of Pharmacology, 142 (4), 756-764. doi: 10.1038/sj.bjp.0705819
2004
Journal Article
Countering cooperative effects in protease inhibitors using constrained b-strand-mimicking templates in focused combinatorial libraries
Reid, Robert C., Pattenden, Lenard K., Tyndall, Joel D. A., Martin, Jennifer L., Walsh, Terry and Fairlie, David P. (2004). Countering cooperative effects in protease inhibitors using constrained b-strand-mimicking templates in focused combinatorial libraries. Journal of Medicinal Chemistry, 47 (7), 1641-1651. doi: 10.1021/jm030337m
Funding
Supervision
Availability
- Dr Robert Reid is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
New strategies in heterocyclic chemistry for drug discovery
Associate Advisor
Other advisors: Dr Jeffrey Mak, Professor David Fairlie
-
Doctor Philosophy
Novel chemical approaches to drugs that selectively target immune cells
Associate Advisor
Other advisors: Dr Jeffrey Mak, Professor David Fairlie
Completed supervision
-
2021
Doctor Philosophy
Towards Design and Synthesis of Novel HDAC Inhibitors
Associate Advisor
Other advisors: Professor David Fairlie
-
2020
Master Philosophy
Towards Inhibitors of HDAC1 with Antiparasitic Activity
Associate Advisor
Other advisors: Professor David Fairlie
-
2017
Doctor Philosophy
Heterocyclic agonists and antagonists for the C3a receptor
Associate Advisor
Other advisors: Professor David Fairlie
-
2014
Doctor Philosophy
Novel Agonists & Antagonists for Protease-Activated Receptor 2 and C3a Receptor
Associate Advisor
Other advisors: Professor David Fairlie
-
2012
Doctor Philosophy
Towards HDAC Selective Inhibitors
Associate Advisor
Other advisors: Professor David Fairlie
-
2008
Doctor Philosophy
Ligands For C3a and C5a Receptors
Associate Advisor
Other advisors: Professor David Fairlie
-
2008
Master Philosophy
Design and Synthesis of HDAC inhibitors derived from a-aminosuberic acid
Associate Advisor
Other advisors: Professor David Fairlie
Media
Enquiries
Contact Dr Robert Reid directly for media enquiries about:
- Chemical Analysis
- HPLC
- LCMS
- Medicinal Chemistry
- NMR
- Organic Chemistry
- Organic Synthesis
- Spectroscopy
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: